In patients with cirrhosis of liver cell growth factor and hyaluronic acid and the relationship between Child-puhg classification.docVIP

 PAGE \* MERGEFORMAT 4 In patients with cirrhosis of liver cell growth factor and hyaluronic acid and the relationship between Child-puhg classification [Abstract] Objective To study the serum of patients with cirrhosis of liver cell growth factor (HGF) and hyaluronic acid (HA) and Child-puhg grading correlation. Methods ELISA method and radioimmunoassay (RIA) measured 87 patients with liver cirrhosis and 35 normal controls serum levels of HGF and HA. The results with liver cirrhosis Child-A, Child-B, Child-C levels in patients, HGF in turn increased the level of liver fibrosis markers in turn increased HA levels, and the difference was significant. The level of HGF and HA was significantly positive correlation. Elevated levels of HGF and HA with the Child-puhg classification consistency. Conclusion Serum HGF level may reflect the severity of liver cirrhosis is to assess the organization fibers in patients with cirrhosis sensitive and accurate indicators to assess the risk of surgical treatment, patient’s condition and prognosis of certain clinical reference value. [Keywords:] liver cirrhosis; hepatocyte growth factor; hyaluronic acid; Child-puhg classification In the liver, HGF secreted mainly by stromal cells and stimulate liver cell growth. The main pathological changes in liver cirrhosis of liver cell necrosis, interstitial cell proliferation. The author of 87 patients with cirrhosis of serum HGF and HA levels were detected, and patients with Child-puhg classification [1], to explore in patients with cirrhosis of serum HA levels of HGF and Child-puhg grading correlation. 1 Data and methods 1.1 General Information 87 patients with liver cirrhosis patient group, male 56 cases, 31 females, aged 30 to 71 years, with an average 52.6 years old, are in line with 2000 Chinese Medical Association credits will be infectious and parasitic diseases, liver credits will be revised ‘ viral hepatitis prevention and treatment programs’ diagnosis and classificat